Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth ...

One of the biggest gripes around weight loss medications like Wegovy and Zepbound is the high price tag. At $1,000 or more a ...

Eli Lilly is dropping CVS Health's drug benefit plan for its employees after the healthcare conglomerate stopped covering the company's weight-loss drug in favor of Novo Nordisk's rival medication, ...

In 2026 patents on semaglutide (the active ingredient in Wegovy and Ozempic) will expire in large emerg­ing markets including ...

Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

We made several strategic additions during market weakness including Fast Retailing, Chipotle, Gartner and Adyen. Read more here.

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

Report is The Hill’s midday newsletter. Subscribe here. Happy Thursday. Thanksgiving is three weeks from today! But don’t ...

Metsera called Pfizer's claims "nonsense" in a follow-up Monday to Pfizer's lawsuit against Metsera and Novo Nordisk.

Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." By now, your news feed, your dinner table conversations, and your doctor’s office have been flooded with ...